Purdue Pharma L.P.

Track this case

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

November 24, 2025
Judge Explains OK For Purdue Ch. 11, Yellow Plan Confirmed

A judge provided his reasons for approving Purdue's revised Chapter 11 plan, and Yellow Corp. and business internet service provider Everstream Solutions both obtained confirmation for their bankruptcy plans.
November 18, 2025
Purdue's $7.4B Ch. 11 Plan Jibes With New Release Paradigm

A New York bankruptcy judge gave a bench ruling Tuesday explaining his decision to confirm Purdue's $7.4 billion Chapter 11 plan, which transforms the pharmaceutical giant into a public benefit company, ruling that liability releases fully comply with new restrictions imposed by the U.S. Supreme Court last year.
November 17, 2025
Purdue, Sunnova Score Approvals For Ch. 11 Plans

Purdue Pharma secured a judge's approval of its new bankruptcy plan. The U.S. Supreme Court won't review a ruling regarding the Serta Simmons Chapter 11 plan. And solar panel company Sunnova also got a court's permission to implement a bankruptcy plan.
November 14, 2025
Purdue's $7.4B Ch. 11 Plan To Be Confirmed

A New York bankruptcy judge agreed to confirm the $7.4 billion Chapter 11 plan of Purdue Pharma LP on Friday, saying he would issue a formal bench ruling next Tuesday explaining his decision.
November 13, 2025
Objecting Claimants Have Their Say On Purdue Ch. 11 Plan

A New York bankruptcy judge heard statements from more than a dozen opioid personal injury claimants objecting to the Chapter 11 plan of OxyContin maker Purdue Pharma Thursday as the pro se objectors shared concerns about their recoveries, the lack of criminal prosecution of the company's owners and faults in the system that allowed the opioid crisis to occur in the first place.
November 12, 2025
Purdue Kicks Off Ch. 11 Confirmation With Plan Overview

Bankrupt OxyContin maker Purdue Pharma began its Chapter 11 confirmation trial Wednesday with an overview of its latest plan and the myriad settlements that underpin the proposal, including a $6.5 billion commitment from the company's owners.
November 07, 2025
Purdue Expects Smooth Confirmation Of New $7.5B Plan

Bankrupt drugmaker Purdue Pharma will begin a confirmation trial for its latest Chapter 11 plan Wednesday in a vastly different position than the last time it came to court seeking similar relief in 2021, when a New York judge approved a plan — over the objections of key parties — that was later struck down by the U.S. Supreme Court.
November 07, 2025
What's Happening In Bankruptcy Court This Coming Week

It's a confirmation-seeking bonanza in the coming week as the Archdiocese of New Orleans will come to court for a pretrial conference related to its bankruptcy plan, Purdue will seek confirmation of its Chapter 11 plan, and Yellow Corp. will make its own bid for plan approval.
October 27, 2025
Purdue Defends Ch. 11 Plan, Heritage Coal's Gets OK'd

Pharmaceutical titan Purdue Pharma hailed support for its proposed bankruptcy plan and fought an objection from the city of Baltimore, Heritage Coal got its Chapter 11 plan approved, and a Texas bankruptcy judge granted LifeScan's conditional approval. This is the week in bankruptcy.
October 22, 2025
Purdue Fights Baltimore Objection Ahead Of Ch. 11 Plan Trial

Purdue Pharma LP told a New York bankruptcy judge on Wednesday it is concerned a recent objection to its Chapter 11 plan brought by the city of Baltimore could disrupt its case just weeks before the drugmaker is set to begin trial on a deal that creditors overwhelmingly support.

← Previous
1
2
3
4
5
6
7
8
9
…
Next →